UK firms advance GPCR project
A collaboration between Peakdale Molecular and fellow UK firm De Novo Pharma has made progress in identifying novel molecules targeting G protein-coupled receptors.
Archives for November 4, 2003
Astex buys metaGen for cancer research
UK firm Astex Technology says that it has acquired German cancer specialist metaGen, a spin-out from European drug major Schering AG, in an all-share transaction.
Hoefliger completes BioProgress deal
BioProgress has signed a formal contract with Harro Hoefliger to make the latter the exclusive builder, supplier and service provider for its non-gelatine encapsulation machines.
Accessories for Millipore water systems
Millipore yesterday launched a range of accessories designed to improve the monitoring of the purity and quality of water generated with its Elix and RiOs systems.
CIMA ditches aaiPharma for Cephalon
Cephalon is to acquire CIMA Laboratories, best known for its dissolve-on-the-tongue tablet technology, for $515 million (€449m) in cash.
Pharmacogenomics: the FDA's view
The US Food and Drug Administration (FDA) yesterday issued a new document that encourages drug and biologic developers to conduct pharmacogenomic tests during drug development and clarifies how the agency will evaluate the resulting data.
Towards high-throughput gene silencing
Dharmacon has entered into a collaboration with fellow US firm Akceli to explore new ways of conducting high-throughput gene function analysis, target validation and drug discovery.
Net loss in 3Q for Flamel
Flamel Technologies dips back into loss in the third quarter but expects to be cash-flow positive for the year as a whole. License and research revenues rise to $4.2m.
Bayer Chemicals launches into turbulent seas
Bayer Chemicals became a separate legal entity from the rest of the Bayer group just over one month ago, having operated as a virtual company since the middle of 2002. The company gave its first press conference at the CPhI meeting last week to...